-
1
-
-
34247481531
-
Tumor dormancy and cancer stem cells: Implications for the biology and treatment of breast cancer metastasis
-
Allan AL, Vantyghem SA, Tuck AB, Chambers AF. Tumor dormancy and cancer stem cells: Implications for the biology and treatment of breast cancer metastasis. Breast Dis 2006; 26: 87-98
-
(2006)
Breast Dis
, vol.26
, pp. 87-98
-
-
Allan, A.L.1
Vantyghem, S.A.2
Tuck, A.B.3
Chambers, A.F.4
-
2
-
-
31444447160
-
Extending survival with chemotherapy in metastatic breast cancer
-
OShaughnessy J. Extending survival with chemotherapy in metastatic breast cancer. Oncologist 2005; 10(Suppl 3): 20-29
-
(2005)
Oncologist
, vol.10
, Issue.SUPPL. 3
, pp. 20-29
-
-
O'Shaughnessy, J.1
-
3
-
-
0037341302
-
SWAP-70-like adapter of T cells, an adapter protein that regulates early TCR-initiated signaling in Th2 lineage cells
-
Tanaka Y, Bi K, Kitamura R, Hong S, Altman Y, Matsumoto A et al. SWAP-70-like adapter of T cells, an adapter protein that regulates early TCR-initiated signaling in Th2 lineage cells. Immunity 2003; 18: 403-414
-
(2003)
Immunity
, vol.18
, pp. 403-414
-
-
Tanaka, Y.1
Bi, K.2
Kitamura, R.3
Hong, S.4
Altman, Y.5
Matsumoto, A.6
-
4
-
-
65849304139
-
The ectopic expression of IFN regulatory factor 4-binding protein is correlated with the malignant behavior of human breast cancer cells
-
Li P, Zhang Z, Wang Q, Li S, Zhang Y, Bian X et al. The ectopic expression of IFN regulatory factor 4-binding protein is correlated with the malignant behavior of human breast cancer cells. Int Immunopharmacol 2009; 9: 1002-1009
-
(2009)
Int Immunopharmacol
, vol.9
, pp. 1002-1009
-
-
Li, P.1
Zhang, Z.2
Wang, Q.3
Li, S.4
Zhang, Y.5
Bian, X.6
-
5
-
-
48249156591
-
Autophagy: An emerging target for cancer therapy
-
Hoyer-Hansen M, Jaattela M. Autophagy: An emerging target for cancer therapy. Autophagy 2008; 4: 574-580
-
(2008)
Autophagy
, vol.4
, pp. 574-580
-
-
Hoyer-Hansen, M.1
Jaattela, M.2
-
6
-
-
20344387475
-
Autophagy: Dual roles in life and death?
-
Baehrecke EH. Autophagy: Dual roles in life and death? Nat Rev Mol Cell Biol 2005; 6: 505-510
-
(2005)
Nat Rev Mol Cell Biol
, vol.6
, pp. 505-510
-
-
Baehrecke, E.H.1
-
7
-
-
0346998038
-
Defective autophagy leads to cancer
-
Edinger AL, Thompson CB. Defective autophagy leads to cancer. Cancer Cell 2003; 4: 422-424
-
(2003)
Cancer Cell
, vol.4
, pp. 422-424
-
-
Edinger, A.L.1
Thompson, C.B.2
-
8
-
-
0000906170
-
Induction of autophagy and inhibition of tumorigenesis by beclin 1
-
Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 1999; 402: 672-676
-
(1999)
Nature
, vol.402
, pp. 672-676
-
-
Liang, X.H.1
Jackson, S.2
Seaman, M.3
Brown, K.4
Kempkes, B.5
Hibshoosh, H.6
-
9
-
-
9144240441
-
Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene
-
Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh H, Troxel A et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 2003; 112: 1809-1820
-
(2003)
J Clin Invest
, vol.112
, pp. 1809-1820
-
-
Qu, X.1
Yu, J.2
Bhagat, G.3
Furuya, N.4
Hibshoosh, H.5
Troxel, A.6
-
10
-
-
34147193472
-
Cell biology: Autophagy and cancer
-
Levine B. Cell biology: Autophagy and cancer. Nature 2007; 446: 745-747
-
(2007)
Nature
, vol.446
, pp. 745-747
-
-
Levine, B.1
-
11
-
-
37549056216
-
The roles of therapy-induced autophagy and necrosis in cancer treatment
-
Amaravadi RK, Thompson CB. The roles of therapy-induced autophagy and necrosis in cancer treatment. Clin Cancer Res 2007; 13: 7271-7279
-
(2007)
Clin Cancer Res
, vol.13
, pp. 7271-7279
-
-
Amaravadi, R.K.1
Thompson, C.B.2
-
12
-
-
34347404887
-
Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis
-
Karantza-Wadsworth V, Patel S, Kravchuk O, Chen G, Mathew R, Jin S et al. Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes Dev 2007; 21: 1621-1635
-
(2007)
Genes Dev
, vol.21
, pp. 1621-1635
-
-
Karantza-Wadsworth, V.1
Patel, S.2
Kravchuk, O.3
Chen, G.4
Mathew, R.5
Jin, S.6
-
13
-
-
66449099090
-
Autophagy suppresses tumorigenesis through elimination of p62
-
Mathew R, Karp CM, Beaudoin B, Vuong N, Chen G, Chen HY et al. Autophagy suppresses tumorigenesis through elimination of p62. Cell 2009; 137: 1062-1075
-
(2009)
Cell
, vol.137
, pp. 1062-1075
-
-
Mathew, R.1
Karp, C.M.2
Beaudoin, B.3
Vuong, N.4
Chen, G.5
Chen, H.Y.6
-
14
-
-
79951607477
-
Downregulation of autophagy by Bcl-2 promotes MCF7 breast cancer cell growth independent of its inhibition of apoptosis
-
Oh S, Xiaofei E, Ni D, Pirooz SD, Lee JY, Lee D et al. Downregulation of autophagy by Bcl-2 promotes MCF7 breast cancer cell growth independent of its inhibition of apoptosis. Cell Death Differ 2011; 18: 452-464
-
(2011)
Cell Death Differ
, vol.18
, pp. 452-464
-
-
Oh, S.1
Xiaofei, E.2
Ni, D.3
Pirooz, S.D.4
Lee, J.Y.5
Lee, D.6
-
15
-
-
1542269066
-
DEF6 a novel PH-DH-like domain protein, is an upstream activator of the Rho GTPases Rac1, Cdc42, and RhoA
-
Mavrakis KJ, McKinlay KJ, Jones P, Sablitzky F. DEF6 a novel PH-DH-like domain protein, is an upstream activator of the Rho GTPases Rac1, Cdc42, and RhoA. Exp Cell Res 2004; 294: 335-344
-
(2004)
Exp Cell Res
, vol.294
, pp. 335-344
-
-
Mavrakis, K.J.1
McKinlay, K.J.2
Jones, P.3
Sablitzky, F.4
-
16
-
-
43049131769
-
Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations
-
LoPiccolo J, Blumenthal GM, Bernstein WB, Dennis PA. Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations. Drug Resist Updat 2008; 11: 32-50
-
(2008)
Drug Resist Updat
, vol.11
, pp. 32-50
-
-
LoPiccolo, J.1
Blumenthal, G.M.2
Bernstein, W.B.3
Dennis, P.A.4
-
17
-
-
51449095342
-
Targeting the PI3K-AKT-mTOR pathway: Progress, pitfalls, and promises
-
Yap TA, Garrett MD, Walton MI, Raynaud F, de Bono JS, Workman P. Targeting the PI3K-AKT-mTOR pathway: Progress, pitfalls, and promises. Curr Opin Pharmacol 2008; 8: 393-412
-
(2008)
Curr Opin Pharmacol
, vol.8
, pp. 393-412
-
-
Yap, T.A.1
Garrett, M.D.2
Walton, M.I.3
Raynaud, F.4
De Bono, J.S.5
Workman, P.6
-
18
-
-
2342559981
-
The TOR pathway: A target for cancer therapy
-
Bjornsti MA, Houghton PJ. The TOR pathway: A target for cancer therapy. Nat Rev Cancer 2004; 4: 335-348
-
(2004)
Nat Rev Cancer
, vol.4
, pp. 335-348
-
-
Bjornsti, M.A.1
Houghton, P.J.2
-
19
-
-
24944480788
-
The Akt-mTOR tango and its relevance to cancer
-
Hay N. The Akt-mTOR tango and its relevance to cancer. Cancer Cell 2005; 8: 179-183
-
(2005)
Cancer Cell
, vol.8
, pp. 179-183
-
-
Hay, N.1
-
20
-
-
34347220473
-
Defining the role of mTOR in cancer
-
Guertin DA, Sabatini DM. Defining the role of mTOR in cancer. Cancer Cell 2007; 12: 9-22
-
(2007)
Cancer Cell
, vol.12
, pp. 9-22
-
-
Guertin, D.A.1
Sabatini, D.M.2
-
21
-
-
34047095297
-
The two TORCs and Akt
-
Bhaskar PT, Hay N. The two TORCs and Akt. Dev Cell 2007; 12: 487-502
-
(2007)
Dev Cell
, vol.12
, pp. 487-502
-
-
Bhaskar, P.T.1
Hay, N.2
-
22
-
-
81155123660
-
The mTOR (mammalian target of rapamycin) kinase maintains integrity of mTOR complex 2
-
Chen CH, Sarbassov dos D. The mTOR (mammalian target of rapamycin) kinase maintains integrity of mTOR complex 2. J Biol Chem 2011; 286: 40386-40394
-
(2011)
J Biol Chem
, vol.286
, pp. 40386-40394
-
-
Chen, C.H.1
Sarbassov Dos, D.2
-
23
-
-
33751348056
-
Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1
-
Guertin DA, Stevens DM, Thoreen CC, Burds AA, Kalaany NY, Moffat J et al. Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. Dev Cell 2006; 11: 859-871
-
(2006)
Dev Cell
, vol.11
, pp. 859-871
-
-
Guertin, D.A.1
Stevens, D.M.2
Thoreen, C.C.3
Burds, A.A.4
Kalaany, N.Y.5
Moffat, J.6
-
24
-
-
36448940798
-
FoxO3 controls autophagy in skeletal muscle in vivo
-
Mammucari C, Milan G, Romanello V, Masiero E, Rudolf R, Del Piccolo P et al. FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab 2007; 6: 458-471
-
(2007)
Cell Metab
, vol.6
, pp. 458-471
-
-
Mammucari, C.1
Milan, G.2
Romanello, V.3
Masiero, E.4
Rudolf, R.5
Del Piccolo, P.6
-
25
-
-
75749122303
-
Methods in mammalian autophagy research
-
Mizushima N, Yoshimori T, Levine B. Methods in mammalian autophagy research. Cell 2010; 140: 313-326
-
(2010)
Cell
, vol.140
, pp. 313-326
-
-
Mizushima, N.1
Yoshimori, T.2
Levine, B.3
-
26
-
-
34248583762
-
Methods for monitoring autophagy from yeast to human
-
Klionsky DJ, Cuervo AM, Seglen PO. Methods for monitoring autophagy from yeast to human. Autophagy 2007; 3: 181-206
-
(2007)
Autophagy
, vol.3
, pp. 181-206
-
-
Klionsky, D.J.1
Cuervo, A.M.2
Seglen, P.O.3
-
27
-
-
27944504351
-
P62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtininduced cell death
-
Bjorkoy G, Lamark T, Brech A, Outzen H, Perander M, Overvatn A et al. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtininduced cell death. J Cell Biol 2005; 171: 603-614
-
(2005)
J Cell Biol
, vol.171
, pp. 603-614
-
-
Bjorkoy, G.1
Lamark, T.2
Brech, A.3
Outzen, H.4
Perander, M.5
Overvatn, A.6
-
28
-
-
34548259958
-
P62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy
-
Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, Outzen H et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 2007; 282: 24131-24145
-
(2007)
J Biol Chem
, vol.282
, pp. 24131-24145
-
-
Pankiv, S.1
Clausen, T.H.2
Lamark, T.3
Brech, A.4
Bruun, J.A.5
Outzen, H.6
-
29
-
-
53549084325
-
Does bafilomycin A1 block the fusion of autophagosomes with lysosomes?
-
Klionsky DJ, Elazar Z, Seglen PO, Rubinsztein DC. Does bafilomycin A1 block the fusion of autophagosomes with lysosomes? Autophagy 2008; 4: 849-950
-
(2008)
Autophagy
, vol.4
, pp. 849-950
-
-
Klionsky, D.J.1
Elazar, Z.2
Seglen, P.O.3
Rubinsztein, D.C.4
-
30
-
-
78649634631
-
Targeting apoptotic and autophagic pathways for cancer therapeutics
-
Liu JJ, Lin M, Yu JY, Liu B, Bao JK. Targeting apoptotic and autophagic pathways for cancer therapeutics. Cancer Lett 2011; 300: 105-114
-
(2011)
Cancer Lett
, vol.300
, pp. 105-114
-
-
Liu, J.J.1
Lin, M.2
Yu, J.Y.3
Liu, B.4
Bao, J.K.5
-
31
-
-
62449266454
-
TORC-specific phosphorylation of mammalian target of rapamycin (mTOR): Phospho-Ser2481 is a marker for intact mTOR signaling complex 2
-
Copp J, Manning G, Hunter T. TORC-specific phosphorylation of mammalian target of rapamycin (mTOR): Phospho-Ser2481 is a marker for intact mTOR signaling complex 2. Cancer Res 2009; 69: 1821-1827
-
(2009)
Cancer Res
, vol.69
, pp. 1821-1827
-
-
Copp, J.1
Manning, G.2
Hunter, T.3
-
32
-
-
0043127125
-
Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
-
Inoki K, Li Y, Xu T, Guan KL. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev 2003; 17: 1829-1834
-
(2003)
Genes Dev
, vol.17
, pp. 1829-1834
-
-
Inoki, K.1
Li, Y.2
Xu, T.3
Guan, K.L.4
-
33
-
-
0036713778
-
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
-
Inoki K, Li Y, Zhu T, Wu J, Guan KL. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol 2002; 4: 648-657
-
(2002)
Nat Cell Biol
, vol.4
, pp. 648-657
-
-
Inoki, K.1
Li, Y.2
Zhu, T.3
Wu, J.4
Guan, K.L.5
-
34
-
-
79960562353
-
Mitochondria of highly metastatic breast cancer cell line MDA-MB-231 exhibits increased autophagic properties
-
Tu YF, Kaipparettu BA, Ma Y, Wong LJ. Mitochondria of highly metastatic breast cancer cell line MDA-MB-231 exhibits increased autophagic properties. Biochim Biophys Acta 2011; 1807: 1125-1132
-
(2011)
Biochim Biophys Acta
, vol.1807
, pp. 1125-1132
-
-
Tu, Y.F.1
Kaipparettu, B.A.2
Ma, Y.3
Wong, L.J.4
-
35
-
-
39849109338
-
Autophagy fights disease through cellular self-digestion
-
Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature 2008; 451: 1069-1075
-
(2008)
Nature
, vol.451
, pp. 1069-1075
-
-
Mizushima, N.1
Levine, B.2
Cuervo, A.M.3
Klionsky, D.J.4
-
36
-
-
33750363298
-
The roles of intracellular protein-degradation pathways in neurodegeneration
-
Rubinsztein DC. The roles of intracellular protein-degradation pathways in neurodegeneration. Nature 2006; 443: 780-786
-
(2006)
Nature
, vol.443
, pp. 780-786
-
-
Rubinsztein, D.C.1
-
37
-
-
48249087666
-
Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells
-
Akar U, Chaves-Reyez A, Barria M, Tari A, Sanguino A, Kondo Y et al. Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells. Autophagy 2008; 4: 669-679
-
(2008)
Autophagy
, vol.4
, pp. 669-679
-
-
Akar, U.1
Chaves-Reyez, A.2
Barria, M.3
Tari, A.4
Sanguino, A.5
Kondo, Y.6
-
38
-
-
77950800322
-
Role of hypoxia and autophagy in MDA-MB-231 invasiveness
-
Indelicato M, Pucci B, Schito L, Reali V, Aventaggiato M, Mazzarino MC et al. Role of hypoxia and autophagy in MDA-MB-231 invasiveness. J Cell Physiol 2010; 223: 359-368
-
(2010)
J Cell Physiol
, vol.223
, pp. 359-368
-
-
Indelicato, M.1
Pucci, B.2
Schito, L.3
Reali, V.4
Aventaggiato, M.5
Mazzarino, M.C.6
-
39
-
-
77956399348
-
HIF1-alpha functions as a tumor promoter in cancer associated fibroblasts, and as a tumor suppressor in breast cancer cells: Autophagy drives compartment-specific oncogenesis
-
Chiavarina B, Whitaker-Menezes D, Migneco G, Martinez-Outschoorn UE, Pavlides S, Howell A et al. HIF1-alpha functions as a tumor promoter in cancer associated fibroblasts, and as a tumor suppressor in breast cancer cells: Autophagy drives compartment-specific oncogenesis. Cell Cycle 2010; 9: 3534-3551
-
(2010)
Cell Cycle
, vol.9
, pp. 3534-3551
-
-
Chiavarina, B.1
Whitaker-Menezes, D.2
Migneco, G.3
Martinez-Outschoorn, U.E.4
Pavlides, S.5
Howell, A.6
-
40
-
-
77957994045
-
Perspectives on inhibiting mTOR as a future treatment strategy for hematological malignancies
-
Chapuis N, Tamburini J, Green AS, Willems L, Bardet V, Park S et al. Perspectives on inhibiting mTOR as a future treatment strategy for hematological malignancies. Leukemia 2010; 24: 1686-1699
-
(2010)
Leukemia
, vol.24
, pp. 1686-1699
-
-
Chapuis, N.1
Tamburini, J.2
Green, A.S.3
Willems, L.4
Bardet, V.5
Park, S.6
-
41
-
-
0037178786
-
Mtor interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery
-
Kim DH, Sarbassov DD, Ali SM, King JE, Latek RR, Erdjument-Bromage H et al. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 2002; 110: 163-175
-
(2002)
Cell
, vol.110
, pp. 163-175
-
-
Kim, D.H.1
Sarbassov, D.D.2
Ali, S.M.3
King, J.E.4
Latek, R.R.5
Erdjument-Bromage, H.6
-
42
-
-
3342895823
-
Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton
-
Sarbassov DD, Ali SM, Kim DH, Guertin DA, Latek RR, Erdjument-Bromage H et al. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol 2004; 14: 1296-1302
-
(2004)
Curr Biol
, vol.14
, pp. 1296-1302
-
-
Sarbassov, D.D.1
Ali, S.M.2
Kim, D.H.3
Guertin, D.A.4
Latek, R.R.5
Erdjument-Bromage, H.6
-
43
-
-
77955443001
-
Critical roles for mTORC2-and rapamycin-insensitive mTORC1-complexes in growth and survival of BCR-ABL-expressing leukemic cells
-
Carayol N, Vakana E, Sassano A, Kaur S, Goussetis DJ, Glaser H et al. Critical roles for mTORC2-and rapamycin-insensitive mTORC1-complexes in growth and survival of BCR-ABL-expressing leukemic cells. Proc Natl Acad Sci USA 2010; 107: 12469-12474
-
(2010)
Proc Natl Acad Sci USA
, vol.107
, pp. 12469-12474
-
-
Carayol, N.1
Vakana, E.2
Sassano, A.3
Kaur, S.4
Goussetis, D.J.5
Glaser, H.6
-
44
-
-
13844312400
-
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
-
Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 2005; 307: 1098-1101
-
(2005)
Science
, vol.307
, pp. 1098-1101
-
-
Sarbassov, D.D.1
Guertin, D.A.2
Ali, S.M.3
Sabatini, D.M.4
-
45
-
-
28844434558
-
Mtor rictor is the ser473 kinase for akt/protein kinase b in 3t3-l1 adipocytes
-
Hresko RC, Mueckler M. mTOR.RICTOR is the Ser473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes. J Biol Chem 2005; 280: 40406-40416
-
(2005)
J Biol Chem
, vol.280
, pp. 40406-40416
-
-
Hresko, R.C.1
Mueckler, M.2
-
46
-
-
4043171462
-
Upstream and downstream of mTOR
-
Hay N, Sonenberg N. Upstream and downstream of mTOR. Genes Dev 2004; 18: 1926-1945
-
(2004)
Genes Dev
, vol.18
, pp. 1926-1945
-
-
Hay, N.1
Sonenberg, N.2
-
47
-
-
13444259647
-
Regulation of cap-dependent translation by eIF4E inhibitory proteins
-
Richter JD, Sonenberg N. Regulation of cap-dependent translation by eIF4E inhibitory proteins. Nature 2005; 433: 477-480
-
(2005)
Nature
, vol.433
, pp. 477-480
-
-
Richter, J.D.1
Sonenberg, N.2
-
48
-
-
80051590039
-
Preclinical characterization of OSI-027, a potent and selective inhibitor of mTORC1 and mTORC2: Distinct from rapamycin
-
Bhagwat SV, Gokhale PC, Crew AP, Cooke A, Yao Y, Mantis C et al. Preclinical characterization of OSI-027, a potent and selective inhibitor of mTORC1 and mTORC2: Distinct from rapamycin. Mol Cancer Ther 2011; 10: 1394-1406
-
(2011)
Mol Cancer Ther
, vol.10
, pp. 1394-1406
-
-
Bhagwat, S.V.1
Gokhale, P.C.2
Crew, A.P.3
Cooke, A.4
Yao, Y.5
Mantis, C.6
-
49
-
-
74549168015
-
Serine 2481-autophosphorylation of mammalian target of rapamycin (mTOR) couples with chromosome condensation and segregation during mitosis: Confocal microscopy characterization and immunohistochemical validation of PP-mTOR(Ser2481) as a novel high-contrast mitosis marker in breast cancer core biopsies
-
Lopez-Bonet E, Vazquez-Martin A, Perez-Martinez MC, Oliveras-Ferraros C, Perez-Bueno F, Bernado L et al. Serine 2481-autophosphorylation of mammalian target of rapamycin (mTOR) couples with chromosome condensation and segregation during mitosis: Confocal microscopy characterization and immunohistochemical validation of PP-mTOR(Ser2481) as a novel high-contrast mitosis marker in breast cancer core biopsies. Int J Oncol 2010; 36: 107-115
-
(2010)
Int J Oncol
, vol.36
, pp. 107-115
-
-
Lopez-Bonet, E.1
Vazquez-Martin, A.2
Perez-Martinez, M.C.3
Oliveras-Ferraros, C.4
Perez-Bueno, F.5
Bernado, L.6
-
50
-
-
77953699668
-
Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer
-
Dalby KN, Tekedereli I, Lopez-Berestein G, Ozpolat B. Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer. Autophagy 2010; 6: 322-329
-
(2010)
Autophagy
, vol.6
, pp. 322-329
-
-
Dalby, K.N.1
Tekedereli, I.2
Lopez-Berestein, G.3
Ozpolat, B.4
-
51
-
-
34547654200
-
SLAT regulates Th1 and Th2 inflammatory responses by controlling Ca2+/NFAT signaling
-
Becart S, Charvet C, Canonigo Balancio AJ, De Trez C, Tanaka Y, Duan W et al. SLAT regulates Th1 and Th2 inflammatory responses by controlling Ca2+/NFAT signaling. J Clin Invest 2007; 117: 2164-2175
-
(2007)
J Clin Invest
, vol.117
, pp. 2164-2175
-
-
Becart, S.1
Charvet, C.2
Canonigo Balancio, A.J.3
De Trez, C.4
Tanaka, Y.5
Duan, W.6
-
52
-
-
73349133350
-
SLAT/Def6 plays a critical role in the development of Th17 cell-mediated experimental autoimmune encephalomyelitis
-
Canonigo-Balancio AJ, Fos C, Prodhomme T, Becart S, Altman A. SLAT/Def6 plays a critical role in the development of Th17 cell-mediated experimental autoimmune encephalomyelitis. J Immunol 2009; 183: 7259-7267
-
(2009)
J Immunol
, vol.183
, pp. 7259-7267
-
-
Canonigo-Balancio, A.J.1
Fos, C.2
Prodhomme, T.3
Becart, S.4
Altman, A.5
-
53
-
-
0037382339
-
Molecular cloning of IBP, a SWAP-70 homologous GEF, which is highly expressed in the immune system
-
Gupta S, Lee A, Hu C, Fanzo J, Goldberg I, Cattoretti G et al. Molecular cloning of IBP, a SWAP-70 homologous GEF, which is highly expressed in the immune system. Hum Immunol 2003; 64: 389-401
-
(2003)
Hum Immunol
, vol.64
, pp. 389-401
-
-
Gupta, S.1
Lee, A.2
Hu, C.3
Fanzo, J.4
Goldberg, I.5
Cattoretti, G.6
-
54
-
-
68149176708
-
Overexpression of the Interferon regulatory factor 4-binding protein in human colorectal cancer and its clinical significance
-
Zhang Z, Wang Q, Li P, Zhou Y, Li S, YiWet al. Overexpression of the Interferon regulatory factor 4-binding protein in human colorectal cancer and its clinical significance. Cancer Epidemiol 2009; 33: 130-136
-
(2009)
Cancer Epidemiol
, vol.33
, pp. 130-136
-
-
Zhang, Z.1
Wang, Q.2
Li, P.3
Zhou, Y.4
Li, S.5
Yi, W.6
-
55
-
-
84870705888
-
Ectopically expressed IBP promotes cell proliferation in oral squamous cell carcinoma
-
Jian CX, Yang MZ, Li P, Xiong J, Zhang ZJ, Li CJ et al. Ectopically expressed IBP promotes cell proliferation in oral squamous cell carcinoma. Cancer Invest 2012; 30: 748-756
-
(2012)
Cancer Invest
, vol.30
, pp. 748-756
-
-
Jian, C.X.1
Yang, M.Z.2
Li, P.3
Xiong, J.4
Zhang, Z.J.5
Li, C.J.6
-
56
-
-
84864795068
-
Interferon regulatory factor 4 binding protein is a novel p53 target gene and suppresses cisplatin-induced apoptosis of breast cancer cells
-
Yang M, Yuan F, Li P, Chen Z, Chen A, Li S et al. Interferon regulatory factor 4 binding protein is a novel p53 target gene and suppresses cisplatin-induced apoptosis of breast cancer cells. Mol Cancer 2012; 11: 54
-
(2012)
Mol Cancer
, vol.11
, pp. 54
-
-
Yang, M.1
Yuan, F.2
Li, P.3
Chen, Z.4
Chen, A.5
Li, S.6
-
57
-
-
84878707525
-
Manipulation of autophagy in cancer cells: An innovative strategy to fight drug resistance
-
Aredia F, Scovassi AI. Manipulation of autophagy in cancer cells: An innovative strategy to fight drug resistance. Future Med Chem 2013; 5: 1009-1021
-
(2013)
Future Med Chem
, vol.5
, pp. 1009-1021
-
-
Aredia, F.1
Scovassi, A.I.2
|